Loading...

FITC anti-mouse/human CD11b Antibody

Pricing & Availability
Clone
M1/70 (See other available formats)
Regulatory Status
RUO
Other Names
αM integrin, Mac-1, Mo1, CR3, Ly-40, C3biR, ITGAM
Isotype
Rat IgG2b, κ
Ave. Rating
Submit a Review
Product Citations
publications
M1slash70_FITC_1_110210
C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_1_110210
    C57BL/6 mouse bone marrow cells were stained with CD11b (clone M1/70) FITC (top) or rat IgG2b, κ FITC isotype control (bottom) (gated on total viable cells).
  • M1slash70_FITC_2_110210
Compare all formats See FITC spectral data
Cat # Size Price Save
101205 50 µg ¥8,370
101206 500 µg ¥24,880
Description

CD11b is a 170 kD glycoprotein also known as αM integrin, Mac-1 α subunit, Mol, CR3, and Ly-40. CD11b is a member of the integrin family, primarily expressed on granulocytes, monocytes/macrophages, dendritic cells, NK cells, and subsets of T and B cells. CD11b non-covalently associates with CD18 (β2 integrin) to form Mac-1. Mac-1 plays an important role in cell-cell interaction by binding its ligands ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, and fibrinogen.

Product Details
Technical data sheet

Product Details

Verified Reactivity
Mouse, Human, Cynomolgus, Rhesus
Reported Reactivity
Chimpanzee, Baboon, Rabbit
Antibody Type
Monoclonal
Host Species
Rat
Immunogen
C57BL/10 splenocytes
Formulation
Phosphate-buffered solution, pH 7.2, containing 0.09% sodium azide.
Preparation
The antibody was purified by affinity chromatography, and conjugated with FITC under optimal conditions.
Concentration
0.5 mg/ml
Storage & Handling
The antibody solution should be stored undiluted between 2°C and 8°C, and protected from prolonged exposure to light. Do not freeze.
Application

FC - Quality tested
Recommended Usage

Each lot of this antibody is quality control tested by immunofluorescent staining with flow cytometric analysis. For flow cytometric staining, the suggested use of this reagent is ≤ 0.25 µg per 106 cells in 100 µl volume. It is recommended that the reagent be titrated for optimal performance for each application.

Excitation Laser
Blue Laser (488 nm)
Application Notes

Clone M1/70 has been verified for immunocytochemistry (ICC) and frozen immunohistochemistry (IHC-F).

Additional reported applications (for relevant formats of this clone) include: immunoprecipitation1,4, in vitro blocking3,9,12, depletion2,8, immunofluorescence microscopy6,7,10, immunohistochemistry of acetone-fixed frozen sections5,11-13, and spatial biology (IBEX)35,36. For in vivo studies or highly sensitive assays, we recommend Ultra-LEAF™ purified antibody (Endotoxin < 0.01 EU/µg, Azide-Free, 0.2 µm filtered) (Cat. No. 101248).

Application References

(PubMed link indicates BioLegend citation)
  1. Springer T, et al. 1978. Eur. J. Immunol. 8:539. (IP)
  2. Ault K and Springer T. 1981. J. Immunol. 126:359. (Deplete)
  3. Springer TA, et al. 1982. Immunol. Rev. 68:171. (Block)
  4. Ho MK and Springer TA. 1983. J. Biol. Chem. 258:2766. (IP)
  5. Flotte TJ, et al. 1983. Am. J. Pathol. 111:112. (IHC)
  6. Noel GJ, et al. 1990. J. Clin. Invest. 85:208. (IF)
  7. Allen LA and Aderem A. 1996. J. Exp. Med. 184:627 (IF)
  8. D'Amico A and Wu L. 2003. J. Exp. Med. 198:293. (Deplete)
  9. Brickson SJ, et al. 2003. Appl Physiol. 95:969. (Block)
  10. Clatworthy MR and Smith KG. 2004. J. Exp. Med. 199:717. (IF)
  11. Hata H, et al. 2004. J. Clin. Invest. 114:582. (IHC)
  12. Zhang Y, et al. 2002. J. Immunol. 168:3088. (IHC)
  13. Iwasaki A and Kelsall BL. 2001. J. Immunol. 166:4884 (IHC, FC)
  14. Tailleux L. 2003. J. Exp. Med. 197:121. (Block, FC)
  15. Olver S, et al. 2006. Cancer Research 66:571. (FC)
  16. Tan SL, et al. 2006. J. Immunol. 176:2872. (FC) PubMed
  17. Ponomarev ED, et al. 2006. J. Immunol. 176:1402. (FC)
  18. Dzhagalov I, et al. 2007. Blood 109:1620. (FC)
  19. Fazilleau N, et al. 2007. Nature Immunol. 8:753.
  20. Rasmussen JW, et al. 2006. Infect. Immun.74:6590. PubMed
  21. Napimoga MH, et al. 2008. J. Immunol. 180:609. PubMed
  22. Elqaraz-Carmon V, et al. 2008. J. Lipid. Res. 49:1894. PubMed
  23. Kim DD, et al. 2008. Blood 112:1109. PubMed
  24. Guo Y, et al. 2008. Blood 112:480. PubMed
  25. Norian LA, et al. 2009. Cancer Res. 69:3086. (FC) PubMed
  26. Baumgartner CK, et al. 2010. J. Immunol. 184:573. PubMed
  27. Charles N, et al. 2010. Nat. Med. 16:701. (FC) PubMed
  28. Whiteland J, et al. 1995. J. Histochem. Cytochem. 43:313. (IHC)
  29. Weber GF, et al. 2014. J Exp Med. 211:1243. PubMed
  30. Ashok A, et al. 2015. Toxicol Sci. 143:64. PubMed
  31. Price PJ, et al. 2015. J Immunol. 194:1164. PubMed
  32. Doni A, et al. 2015. J Exp Med. 212:905. PubMed
  33. Ferreira R, et al. 2016. J Infect Dis. 213: 669 - 673. PubMed
  34. Peterson VM, et al. 2017. Nat. Biotechnol. 35:936. (PG)
  35. Radtke AJ, et al. 2020. Proc Natl Acad Sci U S A. 117:33455-65. (SB) PubMed
  36. Radtke AJ, et al. 2022. Nat Protoc. 17:378-401. (SB) PubMed
Product Citations
  1. Gupta P, Rajan M, Kulkarni S, et al. 2017. Int Immunopharmacol. 10.1016/j.intimp.2017.06.025. PubMed
  2. Haimon Z et al. 2018. Nature immunology. 19(6):636-644 . PubMed
  3. Bijland S, et al. 2019. F1000Res. 8:117. PubMed
  4. Furuhashi K, et al. 2017. Immunology. 151:227. PubMed
  5. Miyatake Y, et al. 2018. J Immunol. 201:3051. PubMed
  6. Wang X, et al. 2019. Cell Res. 29:787. PubMed
  7. Narusawa M, et al. 2014. Cancer Immunol Res. 2:568. PubMed
  8. Ostapoff K, et al. 2014. Cancer Res. 74:4966. PubMed
  9. Fan X, et al. 2015. Cancer Res. 75:86. PubMed
  10. Wang L, et al. 2020. Front Cell Dev Biol. 0.745138889. PubMed
  11. Moreno-García Á, et al. 2020. Biomolecules. 10:00. PubMed
  12. Xue F, et al. 2020. Int J Biol Sci. 2.105555556. PubMed
  13. Petrova T, et al. 2020. Sci Rep. 10:3479. PubMed
  14. Kiepura A, et al. 2021. Int J Mol Sci. 22:. PubMed
  15. Guo H, et al. 2020. Curr Protoc Immunol. 131:e107. PubMed
  16. Xiang G, et al. 2022. Cell Death Dis. 13:451. PubMed
  17. Rosina M, et al. 2022. Cell Metab. 34:533. PubMed
  18. Schädlich IS, et al. 2022. iScience. 25:104470. PubMed
  19. Furrer R, et al. 2021. Sci Adv. 7:eabi4852. PubMed
  20. Li Z, et al. 2022. Nat Commun. 13:1845. PubMed
  21. Bruggemann TR, et al. 2022. iScience. 25:105185. PubMed
  22. Giorgetti E, et al. 2020. Cell Reports. 29(6):1539-1554.e7.. PubMed
  23. Viny AD, et al. 2019. Cell Stem Cell. 25:682. PubMed
  24. Fu R, et al. 2020. Sci Rep. 10:1455. PubMed
  25. Liu W, et al. 2020. Mol Ther Oncolytics. 17:350. PubMed
  26. Huang Z et al. 2017. Cell metabolism. 26(3):493-508 . PubMed
  27. Bo Yu et al. 2018. Cell stem cell. 23(2):193-209 . PubMed
  28. Shavit Stein E, et al. 2018. Neural Plast. 2018:7692182. PubMed
  29. Pathak JL, et al. 2021. Front Cell Dev Biol. 628139:9. PubMed
  30. McNamara HA, et al. 2020. Cell Host Microbe. 572:28. PubMed
  31. Kim JS, et al. 2020. Immunity. 54(1):176-190.e7. PubMed
  32. Rosenkranz SC, et al. 2021. eLife. 10:00. PubMed
  33. Han X, et al. 2017. Int J Mol Sci. 10.3390/ijms18050942. PubMed
  34. Belmonte L, et al. 2016. Sci Rep. 6:35813. PubMed
  35. Nocera D, et al. 2016. J Immunol. 196: 2860 - 2869. PubMed
  36. Jackson A, et al. 2014. J Leukoc Biol. 92:609. PubMed
  37. Tan L, et al. 2022. Biochem Biophys Rep. 32:101351. PubMed
  38. Schönberger K, et al. 2022. Cell Stem Cell. 29:131. PubMed
  39. Di Martile M, et al. 2020. J Immunother Cancer. 8:. PubMed
  40. Gan C, et al. 2022. Respir Res. 23:32. PubMed
  41. He J, et al. 2022. Front Immunol. 12:760138. PubMed
  42. Qi Z, et al. 2022. Nat Commun. 13:182. PubMed
  43. Okajima T, et al. 2021. Front Immunol. 12:738041. PubMed
  44. Zhang Y, et al. 2018. Sci Rep. 8:5994. PubMed
  45. Zhang YS, et al. 2018. Cancer Biol Ther. 19:735. PubMed
  46. Chou YJ, et al. 2020. Sci Rep. 10:8422. PubMed
  47. Wu G, et al. 2020. Front Oncol. 10:194. PubMed
  48. Lee H, et al. 2020. Cell Metabolism. 31(4):822-836. PubMed
  49. Lin R, et al. 2020. Sci Rep. 10:14397. PubMed
  50. Koning B, et al. 2006. Int Immunol. 1.403472222. PubMed
  51. Kapadia D, et al. 2011. PLoS One. 6:e19376. PubMed
  52. Paschall A, et al. 2015. J Immunol. 194: 2369-2379. PubMed
  53. Su N, Xiong Y 2016. Sci Rep. 6:22658. PubMed
  54. Tu S, et al. 2020. Cellular Signalling. 73:109695. PubMed
  55. Pandey S, et al. 2020. Cell Syst. 11:495. PubMed
  56. Tuominen S, et al. 2021. Eur J Nucl Med Mol Imaging. 48:1312. PubMed
  57. Li Y, et al. 2021. Basic Res Cardiol. 116:30. PubMed
  58. Poli V, et al. 2021. iScience. 24:103256. PubMed
  59. Xu ZH, et al. 2021. Mediators Inflamm. 2021:8856326. PubMed
  60. Choi YY, et al. 2021. Cell Death Dis. 12:826. PubMed
  61. Johnson KD, et al. 2022. Blood Adv. 6:1464. PubMed
  62. Zhu ZY, et al. 2022. Front Immunol. 12:781087. PubMed
  63. Chen L, et al. 2022. Mol Ther Oncolytics. 24:522. PubMed
  64. Liang S, et al. 2022. Acta Pharm Sin B. 12:2494. PubMed
  65. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  66. Hu J, et al. 2021. Sci Adv. 7:. PubMed
  67. Chen S, et al. 2022. Cancer Discov. :. PubMed
  68. Patel T, et al. 2022. Aging Cell. 21:e13606. PubMed
  69. Yang W, et al. 2020. Nat Commun. 3.553472222. PubMed
  70. Zaytseva D, et al. 2018. Physiol Rep. 6:e13812. PubMed
  71. Tong X, et al. 2020. Front Pharmacol. 1.404166667. PubMed
  72. Shang W, et al. 2019. J Diabetes Res. 2019:5641271. PubMed
  73. Periasamy S, et al. 2017. Nat Commun. 8:15564. PubMed
  74. Lindborg JA et al. 2017. The Journal of Neuroscience. 37(43):10258-10277 . PubMed
  75. Klichinsky M, et al. 2020. Nat Biotechnol. 38:947. PubMed
  76. Stahnke S, et al. 2021. Current Biology. 31(10):2051-2064.e8. PubMed
  77. Zhang S, et al. 2021. Cell. 184(8):2151-2166.e16. PubMed
  78. Yousif AS, et al. 2020. Immunity. 54(2):235-246.e5. PubMed
  79. Mirshahi F, et al. 2022. Cell Rep. 38:110454. PubMed
  80. Duan M, et al. 2022. Cell Commun Signal. 20:60. PubMed
  81. Zhang Q, et al. 2021. Theranostics. 11:8301. PubMed
  82. Li B, et al. 2022. iScience. 25:103772. PubMed
  83. DeMarco JK, et al. 2021. Vaccines (Basel). 9:. PubMed
  84. Siew JJ, et al. 2019. Nat Commun. 10:3473. PubMed
  85. Verma M, et al. 2018. Brain Behav Immun. 69:223. PubMed
  86. Duarte N, et al. 2018. Hepatol Commun. 0.833333333. PubMed
  87. Di Gioia M, et al. 2020. Nat Immunol. 21:42. PubMed
  88. Pham THM, et al. 2020. Cell Host & Microbe. 27(1):54-67.e5.. PubMed
  89. Guan H, et al. 2012. PLoS One. 7:e35650. PubMed
  90. Caiado F, et al. 2013. Cancer Res. 73:4233. PubMed
  91. Lin T, et al. 2015. PLoS One. 10: e0138335. PubMed
  92. Esmaili S, et al. 2021. Cell Systems. 12(5):432-445.e7. PubMed
  93. Jeong D, et al. 2021. eLife. 0.416666666666667. PubMed
  94. Luff DH, et al. 2021. Front Immunol. 631271:12. PubMed
  95. Yang C, et al. 2020. J Control Release. 326:324. PubMed
  96. Inoue D, et al. 2021. Nat Genet. 53:707. PubMed
  97. Go DM, et al. 2021. Cell Mol Gastroenterol Hepatol. 12:715. PubMed
  98. Tanner MA, et al. 2021. Am J Physiol Heart Circ Physiol. 321:H633. PubMed
  99. Kasper M, et al. 2021. Elife. 10:. PubMed
  100. Bae SH, et al. 2021. Theranostics. 11:2522. PubMed
  101. Helm M, et al. 2022. Life (Basel). 12:. PubMed
  102. Yang W, et al. 2020. Mucosal Immunol. 13:788. PubMed
  103. Peng L, et al. 2020. Transl Lung Cancer Res. 0.892361111. PubMed
  104. Privratsky JR, et al. 2018. Am J Physiol Renal Physiol. 315:F682. PubMed
  105. Luo W, et al. 2019. Mol Med Rep. 20:1007. PubMed
  106. Mayers S, et al. 2019. BMC Biotechnol. 19:21. PubMed
  107. Dey A et al. 2019. The EMBO journal. 38(7) pii: e100293. PubMed
  108. Best SA, et al. 2018. Cell Metab. 27:935. PubMed
  109. Ostendorf BN, et al. 2020. Nat Med. 26:1048. PubMed
  110. Yi M, et al. 2021. J Hematol Oncol. 14:27. PubMed
  111. Periasamy S, et al. 2011. J Leukoc Biol. 90:493. PubMed
  112. Kan C, et al. 2022. Bone Res. 10:62. PubMed
  113. Zhang J, et al. 2021. J Leukoc Biol. 110:485. PubMed
  114. Qiu F, et al. 2022. J Cancer. 13:2893. PubMed
  115. Zhang J, et al. 2022. Front Immunol. 13:931740. PubMed
  116. Hou H, et al. 2021. Front Cell Dev Biol. 9:737003. PubMed
  117. Antunes KH, et al. 2022. Front Immunol. 13:867022. PubMed
  118. Liang P, et al. 2022. Mol Biomed. 3:14. PubMed
  119. Wu Q, et al. 2022. Cell Mol Life Sci. 79:137. PubMed
  120. Li Y, et al. 2022. Clin Transl Immunology. 11:e1362. PubMed
  121. Tanaka Y, et al. 2021. Int J Mol Sci. 22:. PubMed
  122. Kunimoto H, et al. 2018. Cancer Cell. 33:44. PubMed
  123. Zong Z, et al. 2019. Front Immunol. 10:1643. PubMed
  124. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  125. Qi X, et al. 2019. Nat Med. 25:1225. PubMed
  126. Marchingo JM, et al. 2020. eLife. 9:e53725.. PubMed
  127. Lee M, et al. 2014. PLoS One. 9:112666. PubMed
  128. Velázquez K, et al. 2016. Am J Physiol Gastrointest Liver Physiol. 311: G699 - G712. PubMed
  129. Chi Z, et al. 2020. Molecular Cell. 80(1):43-58.e7. PubMed
  130. Dang Y, et al. 2022. Cancer Cell Int. 22:88. PubMed
  131. Almeida AS, et al. 2021. Bio Protoc. 11:e4012. PubMed
  132. Yao L, et al. 2021. J Bone Miner Res. 36:1159. PubMed
  133. Shen Y, et al. 2022. CNS Neurosci Ther. 28:46. PubMed
  134. Rao X, et al. 2022. Cell Death Dis. 13:891. PubMed
  135. Geng T, et al. 2022. Methods Mol Biol. 2585:71. PubMed
  136. Maluski M, et al. 2019. J Clin Invest. 129:5108. PubMed
  137. Perez–Zsolt D, et al. 2019. Front Immunol. 0.989583333. PubMed
  138. Xiao P, et al. 2019. J Exp Med. 216:337. PubMed
  139. Deng Z, et al. 2017. Oncogene. 36:639. PubMed
  140. Varol D et al. 2017. Immunity. 46(6):1030-1044 . PubMed
  141. Ye Z, et al. 2019. Mediators Inflamm. 2019:8709583. PubMed
  142. Marks KE, et al. 2021. Cell Reports. 35(13):109303. PubMed
  143. Ohgomori T, et al. 2020. Neuropharmacology. 176:108227. PubMed
  144. Alshetaiwi H, et al. 2020. Sci Immunol. 5:00. PubMed
  145. Köchl R, et al. 2020. Elife. 9:00. PubMed
  146. Lin D, et al. 2015. Proc Natl Acad Sci U S A. 112: 11324-11329. PubMed
  147. Madan-Lala R, et al. 2014. J Immunol. 192:4263. PubMed
  148. Ippolito G, et al. 2014. Proc Natl Acad Sci U S A. 111:998. PubMed
  149. Yuan F, et al. 2022. Front Immunol. 13:798583. PubMed
  150. Forbester JL, et al. 2020. J Virol. 94:. PubMed
  151. Wu H, et al. 2022. Biomolecules. 12:. PubMed
  152. Zhang B, et al. 2021. Nat Biomed Eng. 5:1288. PubMed
  153. Gao H, et al. 2021. Cells. 10:. PubMed
  154. Saitoh BY, et al. 2021. Brain Behav Immun. 95:362. PubMed
  155. Knolle MD et al. 2018. Frontiers in immunology. 1.925 . PubMed
  156. Doonan J, et al. 2019. Nat Commun. 10:1554. PubMed
  157. Wang F, et al. 2018. Carcinogenesis. 39:889. PubMed
  158. Greenwald AC, et al. 2019. J Exp Med. 216:215. PubMed
  159. Codina A, et al. 2019. Cell Syst. 8:136. PubMed
  160. Srivastava S, et al. 2019. Cancer Cell. 35:489. PubMed
  161. Wang ECE, et al. 2019. Cell Stem Cell. 24:654. PubMed
  162. Schadt L, et al. 2020. Cell Reports. 29(5):1236-1248.e7.. PubMed
  163. Yee PP, et al. 2020. Nat Commun. 4.225. PubMed
  164. Tan A, et al. 2012. Mol Pharmacol. 9:2710. PubMed
  165. Cappello P, et al. 2013. Gastroenterology. 144:1098. PubMed
  166. Meraz I, et al. 2014. PLoS One. 9:94703. PubMed
  167. Aebischer D, et al. 2014. PLoS One. 9:99297. PubMed
  168. Lehmann M, et al. 2016. J Leukoc Biol. 99: 1057 - 1064. PubMed
  169. Lu X, et al. 2016. Nat Commun. 7: 12719. PubMed
  170. Koivisto CS, et al. 2020. Neoplasia. 1.252777778. PubMed
  171. He Y, et al. 2021. Cell Metabolism. 33(5):988-1000.e7. PubMed
  172. Okubo K, et al. 2021. Cell Reports. 35(7):109142. PubMed
  173. Derecka M, et al. 2020. Nat Immunol. 261:21. PubMed
  174. Zhang F, et al. 2020. EMBO Mol Med. e12034:12. PubMed
  175. Dong S, et al. 2021. Nature. 591:117. PubMed
  176. Dang Y, et al. 2021. J Cancer. 12:7158. PubMed
  177. Suryawanshi RK, et al. 2021. Nat Commun. 12:6020. PubMed
  178. Yadav P, et al. 2021. J Immunol. 206:2888. PubMed
  179. Friedman DJ, et al. 2021. Cancer Immunol Res. 9:952. PubMed
  180. Cho YK, et al. 2022. Nat Commun. 13:4084. PubMed
  181. Bao C, et al. 2021. Infect Immun. 89:. PubMed
  182. Dmitrieva‐Posocco O et al. 2019. Immunity. 50(1):166-180 . PubMed
  183. Tavazoie MF, et al. 2018. Cell. 172:825. PubMed
  184. Wang Q, et al. 2018. Nat Commun. 9:559. PubMed
  185. Reismann D, et al. 2017. Nat Commun.. 10.1038/s41467-017-01538-9. PubMed
  186. Wen Y, et al. 2020. Hypertension. 869:75. PubMed
  187. Tacconi C, et al. 2021. Cell Reports. 35(2):108993. PubMed
  188. Elahi S, et al. 2020. Stem Cell Res. 43:101710. PubMed
  189. Osaka M, et al. 2016. Sci Rep. 6:21391. PubMed
  190. Zhou H, et al. 2022. Oncoimmunology. 11:2057892. PubMed
  191. Harnett MM, et al. 2022. Front Immunol. 13:953053. PubMed
  192. Shiraki N, et al. 2022. Stem Cell Reports. 17:221. PubMed
  193. Zhang Y, et al. 2021. J Immunol Res. 2021:5599439. PubMed
  194. Reinfeld BI, et al. 2021. Nature. 593:282. PubMed
  195. Endoh M, et al. 2020. Cell Reports. 30(6):1823-1834. PubMed
  196. Lu X, et al. 2015. J Immunol. 194:2011. PubMed
  197. Miller S, et al. 2016. Acta Biochim Biophys Sin. 48: 334-341. PubMed
  198. Engler AE, et al. 2020. Cell Reports. 33(13):108553. PubMed
  199. Riedelberger M, et al. 2020. Bio Protoc. e3552:10. PubMed
  200. Cho K, et al. 2021. iScience. 24:103117. PubMed
  201. Zhu Y, et al. 2021. EMBO J. 40:e105320. PubMed
  202. Bakker W, et al. 2021. Int J Mol Sci. 22:. PubMed
  203. Li H, et al. 2021. Nat Commun. 12:7149. PubMed
  204. Shan C, et al. 2021. Front Immunol. 12:766401. PubMed
  205. Sobecki M, et al. 2021. Nat Commun. 12:4700. PubMed
  206. Nishida J, et al. 2022. STAR Protoc. 3:101306. PubMed
  207. Yamada KJ, et al. 2020. PLoS Pathog. 16:e1008354. PubMed
  208. Simões FC, et al. 2020. Nat Commun. 0.875. PubMed
  209. Ku AT et al. 2017. eLife. 6 pii: e23242. PubMed
  210. Lei J, et al. 2021. Theranostics. 4251:11. PubMed
  211. Alonso-Herranz L, et al. 2020. Elife. 9:00. PubMed
  212. Chen X, et al. 2016. PLoS One. 11:e0168861. PubMed
  213. Uto T, et al. 2016. Nat Commun. 7: 11273. PubMed
  214. Leon-Rico D, et al. 2015. Lab Anim. 49:132. PubMed
  215. Dong L, et al. 2022. Cells. 11:. PubMed
  216. Li Y, et al. 2022. Front Cardiovasc Med. 9:830781. PubMed
  217. Tang C, et al. 2021. Theranostics. 11:9791. PubMed
  218. Frost JN, et al. 2021. Med (N Y). 2:164. PubMed
  219. Gopinath A, et al. 2022. NPJ Parkinsons Dis. 8:72. PubMed
  220. Sun S, et al. 2021. Front Immunol. 12:777665. PubMed
  221. Jäger M, et al. 2018. Antioxid Redox Signal. 30. PubMed
  222. Nowlan B, et al. 2019. Haematologica. 105:71. PubMed
  223. Liu D, et al. 2020. Front Pharmacol. 11:204. PubMed
  224. Merlo LM, et al. 2020. Clin Pathol. 13:2632010X20951812. PubMed
  225. Quenum Zangbede FO, et al. 2018. J Neurosci. 38:6737. PubMed
  226. Ding X, et al. 2015. J Immunol. 194:4251. PubMed
  227. Wang H, et al. 2020. Nat Mater. 1.655555556. PubMed
  228. Takesue S, et al. 2020. Int J Oncol. 56:596. PubMed
  229. Wei Z, et al. 2021. Nat Commun. 0.805555556. PubMed
  230. Penkert RR, et al. 2020. Obesity (Silver Spring). 1631:28. PubMed
  231. Taddio MF, et al. 2021. Mol Imaging Biol. 23:196. PubMed
  232. Xu Q, et al. 2021. Theranostics. 11:1937. PubMed
  233. Liu P, et al. 2022. iScience. 25:103867. PubMed
  234. Vasudevan SO, et al. 2022. Cell Rep. 39:110755. PubMed
  235. Ryan NM, et al. 2022. Front Immunol. 13:932742. PubMed
  236. Niemi JP, et al. 2020. Methods Mol Biol. 2143:207. PubMed
  237. Dionisio-Santos DA, et al. 2021. Front Neurosci. 15:758677. PubMed
  238. Chen RJ, et al. 2022. iScience. 25:105595. PubMed
  239. Zhuo Y, et al. 2018. Oncol Rep. 40:2147. PubMed
  240. Ponzetta A, et al. 2020. Cell. 178(2):346-360.e24.. PubMed
  241. Ibrahim ML, et al. 2018. Cell Rep. 25:3036. PubMed
  242. Lima-Junior D, et al. 2017. J Immunol. 10.4049/jimmunol.1700258. PubMed
  243. Dong R, et al. 2021. Frontiers in Immunology. 12:620238. PubMed
  244. Chen S, et al. 2020. Allergy Asthma Immunol Res. 0.922222222. PubMed
  245. Morikawa M, et al. 2016. PLoS One. 11:e0163607. PubMed
  246. Chen F, et al. 2016. J Immunol. 196: 4390 - 4399. PubMed
  247. Stevenson ER, et al. 2022. J Pharmacol Exp Ther. 382:356. PubMed
  248. Chen Y, et al. 2022. Life Sci. 306:120826. PubMed
  249. Ben-Yehuda H, et al. 2021. Mol Neurodegener. 16:39. PubMed
  250. Nechama M, et al. 2018. Nat Commun. 9:1603. PubMed
  251. Wang T et al. 2018. Immunity. 49(3):504-514 . PubMed
  252. Adachi Y, et al. 2019. Nat Commun. 10:3883. PubMed
  253. Ohgomori T et al. 2019. J Comp Neurol. 528(1):14-31 . PubMed
  254. Li S, et al. 2019. Front Neurol. 1.036805556. PubMed
  255. Ostapoff K, et al. 2013. Mol Cancer Ther. 12:1190. PubMed
  256. Macagno M, et al. 2014. J Immunol. 192:5434. PubMed
  257. Chou H, et al. 2015. Proc Natl Acad Sci U S A. 112:2175. PubMed
  258. Quan S, et al. 2015. J Immunol. 194:4175. PubMed
  259. Richardson ET, et al. 2015. PLoS One. 10: 1371. PubMed
  260. Yamamuro T, et al. 2020. Nat Commun. 3.340277778. PubMed
  261. Jiang L, et al. 2020. Cell. 183(5):1219-1233.e18. PubMed
  262. He S, et al. 2021. Front Pharmacol. 12:743837. PubMed
  263. Hua X, et al. 2021. Front Immunol. 12:706027. PubMed
  264. Feng L, et al. 2022. Signal Transduct Target Ther. 7:21. PubMed
  265. Zhang MS, et al. 2022. Nat Commun. 13:954. PubMed
  266. Zhang C, et al. 2021. J Immunother Cancer. 9:. PubMed
  267. Nasser H, et al. 2020. Cell Death Discov. 0.29375. PubMed
  268. Baumann D, et al. 2020. Nat Commun. 1.969444444. PubMed
  269. Kitamura K, et al. 2019. Int J Cardiol Heart Vasc. 23:100344. PubMed
  270. Namkoong H, et al. 2018. PLoS Pathog. 14:e1006955. PubMed
  271. Grayczyk JP et al. 2017. Cell host & microbe. 22(5):678-687 . PubMed
  272. Alter C et al. 2019. Am J Physiol Heart Circ Physiol. 317(1):H190-H200 . PubMed
  273. Spolski R et al. 2019. Elife. 8 pii: e45501. PubMed
  274. Tian D, et al. 2019. Nat Commun. 10:4246. PubMed
  275. Li K, et al. 2020. J Cell Mol Med. 24:13115. PubMed
  276. Damgaard RB et al. 2016. Cell. 166(5):1215-1230 . PubMed
  277. Roderick J, et al. 2014. Proc Natl Acad Sci U S A. 111:14436. PubMed
  278. Li Q, et al. 2022. Front Oncol. 12:841977. PubMed
  279. Rao L, et al. 2020. Nat Commun. 11:4909. PubMed
  280. Zhang GL, et al. 2020. Matrix Biol. 93:25. PubMed
  281. Chen Y, et al. 2022. Nat Commun. 13:4468. PubMed
  282. Huang T, et al. 2022. Nat Commun. 13:3489. PubMed
  283. Mihalik NE, et al. 2021. AAPS PharmSciTech. 22:191. PubMed
  284. Li Y, et al. 2022. STAR Protoc. 3:101364. PubMed
  285. Leary N, et al. 2022. J Extracell Vesicles. 11:e12197. PubMed
  286. Zhou H, et al. 2021. Cell Death Discov. 7:332. PubMed
  287. Golan K et al. 2018. Cell stem cell. 23(4):572-585 . PubMed
  288. Glodde N et al. 2017. Immunity. 47(4):789-802 . PubMed
  289. Fox D, et al. 2020. Nat Commun. 0.986111111. PubMed
  290. Deng M, et al. 2019. J Exp Med. 216:2838. PubMed
  291. Chan JY, et al. 2019. Diabetologia. 62:993. PubMed
  292. Erin N, et al. 2015. Brain Behav Immun. 48: 174-185. PubMed
  293. Zhang T, et al. 2020. JCI Insight. 5:00. PubMed
  294. Zhang D, et al. 2020. Signal Transduct Target Ther. 5:24. PubMed
  295. Matsumoto M, et al. 2021. Cell Host Microbe. 29(6):930-940.e4. PubMed
  296. Yang X, et al. 2021. Bioact Mater. 3150:6. PubMed
  297. Adzika GK, et al. 2021. Front Cell Dev Biol. 9:719351. PubMed
  298. Tang S, et al. 2022. Virol J. 19:32. PubMed
  299. Cui Y, et al. 2022. Front Oncol. 12:732860. PubMed
  300. Deliyannis G, et al. 2021. JCI Insight. 6:. PubMed
  301. Tähtinen S, et al. 2022. Nat Immunol. 23:532. PubMed
  302. Patel C, et al. 2022. Curr Protoc. 2:e400. PubMed
  303. Wagner AK, et al. 2022. iScience. 25:105137. PubMed
  304. Woods B, et al. 2019. Clin Cancer Res. 25:5901. PubMed
  305. Han P, et al. 2020. Sci Adv. 6:eaaz1580. PubMed
  306. Calvente CJ, et al. 2019. J Clin Invest. 130:4091. PubMed
  307. Burton OT, et al. 2018. Clin Exp Allergy. 48:288. PubMed
  308. Ortiz A, et al. 2019. Cancer Cell. 35:33:00. PubMed
  309. Uehara M, et al. 2019. Sci Rep. 9:6535. PubMed
  310. Liu SS, et al. 2021. Immunity. :. PubMed
  311. Zhou JH, et al. 2020. Onco Targets Ther. 7.278472222. PubMed
  312. Sitapara RA, et al. 2020. Mol Med. 26:63. PubMed
  313. Yu H, et al. 2015. PLoS One. 10: 0143001. PubMed
  314. Zhong B, et al. 2013. Sci Signal. 6:35. PubMed
  315. Wang Y, et al. 2022. Nat Commun. 13:1454. PubMed
  316. Zhang XL, et al. 2022. J Am Heart Assoc. 11:e023800. PubMed
  317. Wang X, et al. 2022. Elife. 11:. PubMed
  318. Adzika GK, et al. 2021. Front Cardiovasc Med. 8:719805. PubMed
  319. Chen X, et al. 2021. Cell Death Dis. 12:1123. PubMed
  320. Chen J, et al. 2021. Oncol Lett. 21:409. PubMed
  321. Bartley A, et al. 2018. Front Physiol. 9:1593. PubMed
  322. Geng S, et al. 2019. Sci Adv. 5:eaav2309. PubMed
  323. Arima Y et al. 2017. eLife. 6 pii: e25517. PubMed
  324. Krotova K, et al. 2019. Mol Ther Oncolytics. 15:166. PubMed
  325. Lai NY, et al. 2020. Cell. 180:33:00. PubMed
  326. Liu Z, et al. 2020. STAR Protoc. 1:100029. PubMed
  327. Hegde V, et al. 2015. J Immunol. 194:5211. PubMed
  328. Chen MB, et al. 2020. Cell Rep. 30:4418. PubMed
  329. Tran S, et al. 2020. Immunity. 53(3):627-640.e5. PubMed
  330. Katsuyama T, et al. 2021. Cell Reports. 36(1):109339. PubMed
  331. Goldberg EL, et al. 2021. Cell Metabolism. :. PubMed
  332. Luo ZW, et al. 2021. Int J Nanomedicine. 16:2949. PubMed
  333. Schäfer AL, et al. 2021. Front Immunol. 12:696810. PubMed
  334. Lee A, et al. 2022. Nat Commun. 13:549. PubMed
  335. Shin SH, et al. 2022. Clin Exp Otorhinolaryngol. . PubMed
  336. Palma A, et al. 2022. Front Cell Dev Biol. 10:841548. PubMed
  337. Jia J, et al. 2022. Nat Commun. 13:6804. PubMed
  338. Ribechini E, et al. 2017. Blood Adv. 0.699305556. PubMed
  339. Riopel M, et al. 2019. Mol Metab. 20:89. PubMed
  340. Moriyasu T, et al. 2018. PLoS Negl Trop Dis. 12:e0006197. PubMed
  341. Dai B, et al. 2021. Cell Reports Medicine. 2(8):100381. PubMed
  342. Trivedi S, et al. 2020. Elife. 9:00. PubMed
  343. Chng S, et al. 2016. Sci Rep. 6: 23820. PubMed
  344. Koronyo Y, et al. 2015. Brain. 138: 2399-2422. PubMed
  345. Zhao Y, et al. 2013. J Leukoc Biol. 94:1103. PubMed
  346. Xu Z, et al. 2022. Cell Death Dis. 13:502. PubMed
  347. Wang S, et al. 2022. Blood. 140:171. PubMed
  348. Song X, et al. 2022. Transl Oncol. 15:101306. PubMed
  349. Davis FM, et al. 2021. J Exp Med. 218:. PubMed
  350. Wu KKL, et al. 2021. Nat Commun. 12:6637. PubMed
  351. Amend A, et al. 2021. Int J Mol Sci. 22:. PubMed
  352. Xue Y, et al. 2020. Sci Rep. 10:22265. PubMed
RRID
AB_312788 (BioLegend Cat. No. 101205)
AB_312789 (BioLegend Cat. No. 101206)

Antigen Details

Structure
Integrin family, associates with integrin β2 (CD18), 170 kD
Distribution

Granulocytes, monocytes/macrophages, dendritic cells, NK cells, subsets of T and B cells

Function
Adhesion, chemotaxis
Ligand/Receptor
ICAM-1 (CD54), ICAM-2 (CD102), ICAM-4 (CD242), iC3b, fibrinogen
Cell Type
B cells, Dendritic cells, Granulocytes, Macrophages, Monocytes, Neutrophils, NK cells, T cells, Tregs
Biology Area
Cell Adhesion, Cell Biology, Costimulatory Molecules, Immunology, Innate Immunity, Neuroscience, Neuroscience Cell Markers
Molecular Family
Adhesion Molecules, CD Molecules
Antigen References

1. Barclay A, et al. 1997. The Leukocyte Antigen FactsBook Academic Press.
2. Springer TA. 1994. Cell 76:301.
3. Coxon A, et al. 1996. Immunity 5:653.

Gene ID
16409 View all products for this Gene ID 3684 View all products for this Gene ID
UniProt
View information about CD11b on UniProt.org

Related FAQs

There are no FAQs for this product.

Other Formats

View All CD11b Reagents Request Custom Conjugation
Description Clone Applications
APC anti-mouse/human CD11b M1/70 FC
Biotin anti-mouse/human CD11b M1/70 FC
FITC anti-mouse/human CD11b M1/70 FC
PE anti-mouse/human CD11b M1/70 FC,IHC
PE/Cyanine5 anti-mouse/human CD11b M1/70 FC
Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,IHC-F,ICC
PE/Cyanine7 anti-mouse/human CD11b M1/70 FC
Alexa Fluor® 488 anti-mouse/human CD11b M1/70 FC,IHC-F,3D IHC,SB
Alexa Fluor® 647 anti-mouse/human CD11b M1/70 FC,3D IHC,SB
Alexa Fluor® 700 anti-mouse/human CD11b M1/70 FC
Pacific Blue™ anti-mouse/human CD11b M1/70 FC
APC/Cyanine7 anti-mouse/human CD11b M1/70 FC
PerCP/Cyanine5.5 anti-mouse/human CD11b M1/70 FC
PerCP anti-mouse/human CD11b M1/70 FC
Brilliant Violet 421™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 570™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 605™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 650™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 711™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 785™ anti-mouse/human CD11b M1/70 FC
Brilliant Violet 510™ anti-mouse/human CD11b M1/70 FC,ICC
Ultra-LEAF™ Purified anti-mouse/human CD11b M1/70 FC,CyTOF®,IP,Block,Depletion,IHC-F,ICC
Purified anti-mouse/human CD11b (Maxpar® Ready) M1/70 FC,CyTOF®
Alexa Fluor® 594 anti-mouse/human CD11b M1/70 IHC-F,FC
PE/Dazzle™ 594 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 750 anti-mouse/human CD11b M1/70 FC
TotalSeq™-A0014 anti-mouse/human CD11b M1/70 PG
Brilliant Violet 750™ anti-mouse/human CD11b M1/70 FC
TotalSeq™-B0014 anti-mouse/human CD11b M1/70 PG
TotalSeq™-C0014 anti-mouse/human CD11b M1/70 PG
Spark NIR™ 685 anti-mouse/human CD11b M1/70 FC
PE/Fire™ 640 anti-mouse/human CD11b M1/70 FC
Spark YG™ 593 anti-mouse/human CD11b M1/70 FC
Spark YG™ 570 anti-mouse/human CD11b M1/70 IHC-F
PE/Fire™ 810 anti-mouse/human CD11b M1/70 FC
APC/Fire™ 810 anti-mouse/human CD11b Antibody M1/70 FC
Spark Blue™ 550 anti-mouse/human CD11b M1/70 FC
Spark UV™ 387 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 806 anti-mouse/human CD11b M1/70 FC
PerCP/Fire™ 780 anti-mouse/human CD11b M1/70 FC
Spark Blue™ 574 anti-mouse/human CD11b (Flexi-Fluor™) M1/70 FC
KIRAVIA Blue 520™ anti-mouse/human CD11b M1/70 FC
Spark PLUS UV™ 395 anti-mouse/human CD11b M1/70 FC
Go To Top Version: 1    Revision Date: 11/30/2012

For Research Use Only. Not for diagnostic or therapeutic use.

 

This product is supplied subject to the terms and conditions, including the limited license, located at www.biolegend.com/terms) ("Terms") and may be used only as provided in the Terms. Without limiting the foregoing, BioLegend products may not be used for any Commercial Purpose as defined in the Terms, resold in any form, used in manufacturing, or reverse engineered, sequenced, or otherwise studied or used to learn its design or composition without express written approval of BioLegend. Regardless of the information given in this document, user is solely responsible for determining any license requirements necessary for user’s intended use and assumes all risk and liability arising from use of the product. BioLegend is not responsible for patent infringement or any other risks or liabilities whatsoever resulting from the use of its products.

 

BioLegend, the BioLegend logo, and all other trademarks are property of BioLegend, Inc. or their respective owners, and all rights are reserved.

 

8999 BioLegend Way, San Diego, CA 92121 www.biolegend.com
Toll-Free Phone: 1-877-Bio-Legend (246-5343) Phone: (858) 768-5800 Fax: (877) 455-9587

This data display is provided for general comparisons between formats.
Your actual data may vary due to variations in samples, target cells, instruments and their settings, staining conditions, and other factors.
If you need assistance with selecting the best format contact our expert technical support team.

ProductsHere
Login / Register
Remember me
Forgot your password? Reset password?
Create an Account